Ritesh Thakare

Employment

• Yale University Associate Research Scientist
  2025 - Present
• University of Massachusetts Chan Medical School TH Chan School of Medicine Postdoctoral Research Associate
  2022 - 2025
• Brown University Post doctoral research associate
  2020 - 2022
• Rutgers The State University of New Jersey Post doctoral research associate
  2019 - 2020
• Central Drug Research Institute Ph.D. scholar
  2014 - 2019

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (44)

• Dynamic S-Acylation of GSDMA Regulates Pyroptosis
  ACS Chemical Biology 2026 DOI: 10.1021/acschembio.5c00050
  +Save
• Identification of Rocaglate Acyl Sulfamides as Selective Inhibitors of Glioblastoma Stem Cells
  Zihao Wang, Ritesh Thakare, Shalaka Chitale +12 more
  ACS Central Science 2024 DOI: 10.1021/acscentsci.4c01073
  +Save
• Correction: Satam et al. Next-Generation Sequencing Technology: Current Trends and Advancements. Biology 2023, 12, 997
  Heena Satam, Kandarp Joshi, Upasana Mangrolia +8 more
  Biology 2024 DOI: 10.3390/biology13050286
  +Save
• Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers
  Ravi Bharadwaj, Swati Jaiswal, Erandi Velarde de la Cruz +1 more
  Diseases 2024 DOI: 10.3390/diseases12030063
  +Save
• Indole‐based aryl sulfides target the cell wall of Staphylococcus aureus without detectable resistance
  Aditya G. Lavekar, Ritesh Thakare, Saima Saima +3 more
  Drug Development Research 2024 DOI: 10.1002/ddr.22123
  +Save
• Next-Generation Sequencing Technology: Current Trends and Advancements
  Heena Satam, Kandarp Joshi, Upasana Mangrolia +8 more
  Biology 2023 DOI: 10.3390/biology12070997
  +Save
• Antimicrobial efficacy of a hemilabile Pt(ii)–NHC compound against drug-resistant S. aureus and Enterococcus
  Mandeep Kaur, Ritesh Thakare, Arindom Bhattacherya +7 more
  Dalton Transactions 2023 DOI: 10.1039/D2DT03365H
  +Save
• Aromatic or Hetero-aromatic Directly Attached Tri and Tetrasubstituted Methanes: New Chemical Entities as Anti-infectives
  Deblina Roy, Ritesh Thakare, Sidharth Chopra +1 more
  Current Medicinal Chemistry 2022 DOI: 10.2174/0929867329666220823111812
  +Save
• Update on nifurtimox for treatment of Chagas disease.
  Ritesh Thakare, Amitava Dasgupta, Sidharth Chopra
  Drugs of today (Barcelona, Spain : 1998) 2021 DOI: 10.1358/dot.2021.57.4.3251712
  +Save
• Chitotriosidase Activity Is Counterproductive in a Mouse Model of Systemic Candidiasis
  2021 DOI: 10.3389/fimmu.2021.626798
  +Save
• Fosmanogepix. GPI-anchored wall transfer protein 1 (Gwt1) (fungal) inhibitor, Treatment of invasive fungal infections
  Ritesh Thakare, Amitava Dasgupta, Sidharth Chopra
  Drugs of the Future 2021 DOI: 10.1358/dof.2021.46.4.3223384
  +Save
• TNP-2092. RNA polymerase (bacterial) inhibitor, DNA gyrase (bacterial) inhibitor, DNA topoisomerase IV (bacterial) inhibitor, Treatment of medical device-associated bacterial biofilm infections
  R. Takare, Amitava Dasgupta, Sidharth Chopra
  Drugs of the Future 2021 DOI: 10.1358/DOF.2021.46.2.3176879
  +Save
• Pretomanid for the treatment of pulmonary tuberculosis.
  Ritesh Thakare, Amitava Dasgupta, Sidharth Chopra
  Drugs of today (Barcelona, Spain : 1998) 2020 DOI: 10.1358/dot.2020.56.10.3161237
  +Save
• Lascufloxacin hydrochloride to treat bacterial infection.
  Ritesh Thakare, Sukhvant Singh, Amitava Dasgupta +1 more
  Drugs of today (Barcelona, Spain : 1998) 2020 DOI: 10.1358/dot.2020.56.6.3137167
  +Save
• Imipenem/cilastatin sodium/relebactam fixed combination to treat urinary infections and complicated intra-abdominal bacterial infections.
  Ritesh Thakare, Amitava Dasgupta, Sidharth Chopra
  Drugs of today (Barcelona, Spain : 1998) 2020 DOI: 10.1358/dot.2020.56.4.3075796
  +Save
• Antibiotics: past, present, and future
  2020 DOI: 10.1016/b978-0-12-818480-6.00001-1
  +Save
• Exebacase. Bacteriophage-derived antistaphylococcal lysin, Direct lytic agent, Treatment of S. aureus bacteremia
  Ritesh Thakare, Amitava Dasgupta, Sidharth Chopra
  Drugs of the Future 2020 DOI: 10.1358/dof.2020.45.12.3191005
  +Save
• Repurposing nonantibiotic drugs as antibacterials
  Ritesh Thakare, Grace Kaul, Manjulika Shukla +4 more
  2020 DOI: 10.1016/b978-0-12-818480-6.00005-9
  +Save
• Rezafungin acetate. 1,3-beta-Glucan synthase inhibitor, Antifungal agent
  Sidharth Chopra, Ritesh Thakare, Amitava Dasgupta
  Drugs of the Future 2020 DOI: 10.1358/dof.2020.45.3.3109965
  +Save
• Teixobactin: A Paving Stone toward a New Class of Antibiotics?
  Vidya B. Gunjal, Ritesh Thakare, Sidharth Chopra +1 more
  2020 DOI: 10.1021/acs.jmedchem.0c00173
  +Save